Horizons Ventures | Investment Thesis & Preferences

Horizons Ventures Research

Investment Thesis

Horizons Ventures is a pioneering global venture capital firm founded in 2005 by Solina Chau, investing in deep science and disruptive technology companies that can propel humanity towards a radically better future. The firm operates with a mission to solve fundamental, universal problems—gender inequality, uneven wealth, poor health, climate adaptation—through investments in next-normal companies whose IP and ideas can create lasting impact.

The investment philosophy centers on identifying founders and businesses whose technological innovations address humanity's greatest challenges. Horizons seeks enterprising science and technology companies whose founders demonstrate vision, instinct, and drive to scale solutions with measurable impact.

Sector and Technology Focus

Horizons Ventures maintains a remarkably diversified portfolio spanning multiple sectors:

Core Investment Areas:

Deep Science & Biotechnology: Therapeutic companies, genetic medicine, microbiome, regenerative medicine, cell therapy, protein engineering
Healthcare Technology: AI-driven diagnostics, digital health platforms, medical practice operating systems, telehealth, bioelectronics
Sustainable Technology: Clean energy (hydrogen, renewable materials), environmental solutions, sustainable materials, carbon management
Food & Agriculture: Precision fermentation, alternative proteins, sustainable agriculture, alternative food sources
AI & Machine Learning: AI infrastructure, natural language processing, computer vision, edge AI, bioelectronics powered by AI
Materials Science: Biodegradable materials, bio-engineered proteins, synthetic biology, lab-grown materials
Hardware & Infrastructure: Semiconductors, robotics, autonomous systems, aerospace
Enterprise Software: Practice management systems, workforce optimization, automation
Fintech & Financial Services: Digital banking, financial inclusion, investment platforms
Consumer & Media: Gaming, entertainment, sports technology, education

Technology Tags: AI/ML, Computer Vision, Synthetic Biology, Biotech, Hardware

Stage Focus

Horizons Ventures invests across all stages, with particular emphasis on seed and early-stage companies:

Pre-Seed & Seed: Majority of investments, supporting founders with early-stage technology
Series A & Beyond: Selective follow-on investments in portfolio companies showing strong momentum
Later Stages: Occasional investments in companies approaching scale

The firm is not stage-specific but rather founder and innovation-specific, willing to invest in exceptional teams at any stage.

Check Size & Investment Range

Typical Investment Range: $1M - $25M+

The firm's check sizes vary significantly by stage and company, ranging from smaller seed investments to multi-million dollar Series A and B rounds. Notable recent investments (2024-2025) include therapeutic and AI biotech companies.

Lead Tendency

Leads and Co-Leads: Horizons Ventures frequently leads rounds and takes board seats, but also participates as a co-investor in larger rounds. The firm demonstrates willingness to lead in areas where they have deep expertise and conviction.

Recent Activity & Fund Status

Current Fund Status: Actively Deploying

Horizons recently raised $350 million in new capital (January 2026), significantly expanding its deployment capacity. The firm is in an aggressive investment phase with recent partnerships and funding rounds demonstrating strong capital availability.

Recent Activity Timeline:

January 2026: Raised $350M in new investment capital
2024-2025: Active investments in deep science, AI biotech, therapeutic companies
Recent notable investments: Abalone Bio, CellVoyant, Kimia, Promise Robotics, Chemify, BioLoomics, Cauldron, Doctorly

Portfolio Highlights

Scale of Portfolio: 200-366 total investments demonstrating broad sector coverage

Notable Exits & Success Stories:

DeepMind (acquired by Google) - AI research
Skype (acquired by Microsoft) - Communications
Spotify (IPO) - Music streaming
Facebook (IPO) - Social media
Siri (acquired by Apple) - Voice assistant
Zoom (IPO) - Video conferencing
Celsius (public) - Functional beverages
Impossible Foods (unicorn) - Alternative protein
Waze (acquired by Google) - Navigation

Team

Leadership: Solina Chau founded Horizons Ventures with deep connections to Li Ka-Shing family office network. The firm operates with two integrated teams: "Investing for Impact" and "Supporting to Scale."

The firm has 20+ investment professionals across global offices providing deal sourcing, due diligence, and portfolio support.

Geographic Focus

Global investment strategy with significant presence in:

United States: Primary market, especially Silicon Valley and Boston biotech hubs
United Kingdom: Deep science, materials, biotech
Asia-Pacific: Australia, Indonesia, India, Hong Kong (regional hub)
Europe: Germany, Sweden, Switzerland, Israel, Canada

Founder Preferences

Horizons Ventures explicitly seeks founders and teams with:

Vision for impact: Founders solving fundamental problems
Technical depth: Deep domain expertise, especially in science, engineering, and technology
Founder-market fit: Track record of building products, demonstrated domain knowledge
First-principle thinking: Founders who challenge conventional approaches
Global mindset: Willingness to build companies across borders

Summary

Horizons Ventures is a mature, globally-oriented impact-focused venture capital firm with deep roots in deep science, biotechnology, and transformative technology. With $350M in recent capital raised, a global portfolio of 200+ companies including unicorns like Zoom, Spotify, and Impossible Foods, and a team across 20+ investment professionals, Horizons represents one of the most successful deep-science venture investors globally.

The firm's commitment to solving fundamental human problems combined with conviction in technical founders and early-stage technology investment positions Horizons as a preferred partner for founders building the next generation of transformative companies.